Institutional investors hold a majority ownership of AGN through the 89.14% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2015, these large investors purchased a net $12.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 125.0 Thousand shares of Allergan
QS BATTERYMARCH FINANCIAL MANAGE... Bought 7.2 Thousand shares of Allergan
BLACKROCK INVESTMENT MANAGEMENT ... Bought 3.8 Thousand shares of Allergan